Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799
Ohwada, J., Ebiike, H., Kawada, H., Tsukazaki, M., Nakamura, M., Miyazaki, T., Morikami, K., Yoshinari, K., Yoshida, M., Kondoh, O., Kuramoto, S., Ogawa, K., Aoki, Y., Shimma, N.(2011) Bioorg.Med.Chem.Lett. 21: 1767-1772
- PubMed: 21316229 
- DOI: 10.1016/j.bmcl.2011.01.065
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase and a promising therapeutic target for cancer. Using structure-based drug design (SBDD), we have identified novel PI3K inhibitors with a dihydropyrrolopyrimidine skeleton. Metabolic stability of ...